Navigation Links
Expert Neurology Panel Weighs Impact of New Reports of PML in Multiple Sclerosis Patients on Tysabri

SCOTTSDALE, Ariz., Aug. 20 /PRNewswire/ -- MedPredict, a global provider of pharmaceutical competitive intelligence and market research, has published a new report providing critical strategic insight for pharma and biotech companies with a stake in the market for multiple sclerosis (MS) therapies.

Biogen/Elan's Tysabri has been under scrutiny due to two additional reported cases of PML, a rare and potentially fatal brain disease associated with use of the drug. MedPredict recently convened an expert panel of neurologists to assess the significance of the PML cases, and the effect on prescribing and development of new potent immunosurveillants.

"Nobody at the Thought Leader level was surprised that there were more new (PML) events," according to Jeff Berk, MedPredict's president. "At the time of the reinstatement of the US license for Tysabri, the FDA Advisory Committee stated that they expected there to be more events. Our panel discusses whether that sentiment will translate to community-based neurologists."

The report also updates progress on other approaches to treatment of MS, including:

-- New interferons, integrin inhibitors, B-cell inhibitors, S1Ps, fumarates, neuroprotection/neuroregeneration.

-- The potential for vaccine or MAb approaches for the treatment or prevention of multiple sclerosis.

-- Which therapeutics in development to provide symptomatic benefits in MS are the most likely winners.

MedPredict's analysis also provides guidance for clinical trial design in MS. "There have been a number of high-profile failed trials, both in relapsing-remitting and in progressive MS," said Dr. Berk. "The panel talks about strategies for improving the odds of success through better designs and better metrics."

Companies and partnerships discussed in this report include: Acorda, Amgen/Epix, Artielle ImmunoTherapeutics, Avanir, BaroFold, Bayhill, Bayer-Schering, Bayer-Schering/Genzyme, Biogen, Biogen/Elan, Biogen/Genentech/Roche, Biogen/UCB, Daiichi Sankyo, Genentech, GSK, GSK/Genmab, GSK/Mitsubishi Tanabe, Lilly/BioMS, Merck, Merck-Serono, Novartis, Ono, Opexa, PDL/Biogen/Roche, Peptimmune, Roche/Actelion, Roche/Genentech, Sanofi-Aventis, Teva/Merck-Serono, Teva.

This report can be purchased by contacting MedPredict.

About MedPredict

MedPredict ( maintains a proprietary database of over 1,000 global physician thought leaders, including 40+ specialties in 30+ therapeutic categories. Based on primary interviews with these thought leaders, MedPredict publishes periodic reports in each category to keep clients up-to-date on emerging trends and competitive activity. The reports include thought leader reactions to recent publications and medical conferences, as well as clinical, regulatory and marketing activity.

SOURCE MedPredict
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Duff & Phelps Acquires Lumin Expert Group To Build Global Intellectual Property Practice
2. PerkinElmer Expertise and Solutions Integral to Food Safety Monitoring for the Beijing Games : Methods, Applications Expertise and Instrumentation Deployed in Mobile Laboratory
3. Leading AIDS Experts Urge Greater Focus on Behavior-Change Programs to Prevent HIV
4. Cepheid Introduces GeneXpert(R) Infinity-48 System at 2008 American Association of Clinical Chemistry Meeting
5. is Launched for Manufacturers in Search of Chemical Reactions Expertise
6. Pharmacy Students Taught Improved Medication Adherence and Holistic Health Services Through Program Incorporating InforMedixs Med-eXpert(TM) System
7. Online Career Tool Offers Live Expert Advice Component
8. Expert Consensus Panel Recommendation for Incorporating Lp-PLA2 Testing into Cardiovascular Disease Risk Assessment Guidelines
9. PAREXEL Experts to Address Key Industry Topics at the Drug Information Association 44th Annual Meeting
10. Experts From The Peer Group Provide Training on Dialogue-Based Influence at the SPBT Annual Conference
11. PAREXEL Product Development and Regulatory Experts to Attend the 2008 BIO International Convention
Post Your Comments:
(Date:11/27/2015)... , Nov. 27, 2015 /PRNewswire/--  Mallinckrodt plc (NYSE: ... today that it has closed the sale of its ... Guerbet (GBT- NYSE Euronext) in a transaction valued at ... manufacturing facilities and a total of approximately 1,000 employees ... St. Louis area. This entire ...
(Date:11/26/2015)... England , November 26, 2015 ... medical device company specializing in imaging technologies, announced today that ... Commission as part of the Horizon 2020 European Union Framework ... out a large-scale clinical trial in breast cancer. ... , --> --> ...
(Date:11/25/2015)... 25, 2015 Studies reveal the ... plaque and pave the way for more effective treatment for ...     --> --> ... health problems in cats, yet relatively little was understood about ... studies have been conducted by researchers from the WALTHAM Centre ...
(Date:11/25/2015)... ... 25, 2015 , ... A long-standing partnership between the Academy ... been formalized with the signing of a Memorandum of Understanding. , AMA Executive ... Karl Minter and Capt. Albert Glenn Tuesday, November 24, 2015, at AMA Headquarters ...
Breaking Biology Technology:
(Date:11/2/2015)... MENLO PARK, Calif. , Nov. 2, 2015 /PRNewswire/ ... to $9 million to provide preclinical development services to ... Under the contract, SRI will provide scientific expertise, modern ... a wide variety of preclinical pharmacology and toxicology studies ... --> --> The PREVENT Cancer Drug ...
(Date:10/29/2015)... RESTON, Va. , Oct. 29, 2015 ... announced today that it has released a new version ... Daon customers in North America ... gains. IdentityX v4.0 also includes a FIDO UAF ... customers are already preparing to activate FIDO features. These ...
(Date:10/29/2015)... 29, 2015 NXTD ) ... focused on the growing mobile commerce market and ... StackCommerce, a leading marketplace to discover and buy ... smart wallet on StackSocial for this holiday season. ... the "Company"), a biometric authentication company focused on ...
Breaking Biology News(10 mins):